The COVID-19 ICU PRAYER Study
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04361838 |
Recruitment Status :
Terminated
(Due to the low enrollment, this study is closed. Analysis of data is not performed.)
First Posted : April 24, 2020
Last Update Posted : February 3, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Coronavirus Infection | Behavioral: prayer | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 200 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Participant, Care Provider) |
Primary Purpose: | Supportive Care |
Official Title: | Impact of Multi-Denominational Prayer on Morbidity and Mortality of Patients Admitted to the Intensive Care Unite With Corona Virus Infection |
Actual Study Start Date : | May 21, 2020 |
Actual Primary Completion Date : | April 30, 2021 |
Actual Study Completion Date : | April 30, 2021 |

Arm | Intervention/treatment |
---|---|
Active Comparator: Prayer
Patients will receive a daily prayer and standard of care treatment from multi-denominational group while in the ICU.
|
Behavioral: prayer
receive prayers daily while in ICU |
No Intervention: No Prayer
Patients will receive standard of care treatment while in the ICU.
|
- Impact of multi-denominational prayer on clinical outcomes of critically ill COVID-19 patients in the Intensive Care Unit on mortality. [ Time Frame: daily until patient recovers and moves out of ICU or exits the study, up to 30 days ]This study will measure the difference in mortality of COVID-19 patients who are admitted to ICU - given prayer vs no prayer as an adjunct to standard therapy.
- Difference in patient outcomes - Acute Physiology and Chronic Health Enquiry. APACHE II score. [ Time Frame: daily until patient recovers and moves out of ICU or exits the study, up to 30 days. ]APACHE II uses 0-71 scale, the higher the score the higher the risk for mortality.
- Difference in patient outcomes - Sequential Organ Failure Assessment - SOFA Score [ Time Frame: daily until patient recovers and moves out of ICU or exits the study, up to 30 days ]The higher the SOFA score the increased likelihood of organ failure.
- Difference in patient outcomes - Length of stay in ICU. [ Time Frame: daily until patient recovers and moves out of ICU or exits the study, up to 30 days ]A prolonged length of time in ICU increases mortality.
- Difference in patient outcomes - Length of ventilator support [ Time Frame: daily until patient recovers and moves out of ICU or exits the study, up to 30 days ]A prolonged length of time with ventilator support increases mortality.
- Difference in patient outcomes - length of vasopressor support [ Time Frame: daily until patient recovers and moves out of ICU or exits the study, up to 30 days ]A prolonged length of time with vasopressor support increases recovery time.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 110 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Male or female greater than 18 years of age
- Confirmed positive for COVID-19
- Patient admitted to Intensive Care Unit
Exclusion Criteria:
- Patients admitted to ICU for diagnosis that is not COVID-19 positive.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04361838
United States, Missouri | |
Research Medical Center | |
Kansas City, Missouri, United States, 64132 |
Principal Investigator: | Dhanunjaya Lakkireddy, MD | Kansas City Heart Rhythm Institute |
Responsible Party: | Kansas City Heart Rhythm Institute |
ClinicalTrials.gov Identifier: | NCT04361838 |
Other Study ID Numbers: |
Covid Prayer Study |
First Posted: | April 24, 2020 Key Record Dates |
Last Update Posted: | February 3, 2022 |
Last Verified: | February 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Infections Coronavirus Infections Coronaviridae Infections |
Nidovirales Infections RNA Virus Infections Virus Diseases |